cosyntropin and Opsoclonus-Myoclonus-Syndrome

cosyntropin has been researched along with Opsoclonus-Myoclonus-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for cosyntropin and Opsoclonus-Myoclonus-Syndrome

Article	Year
Rituximab, IVIg, and Tetracosactide (ACTH1-24) Combination Immunotherapy ("RITE-CI") for Pediatric Opsoclonus-Myoclonus Syndrome: Immunomarkers and Clinical Observations. Neuropediatrics, 2018, Volume: 49, Issue:2 Topics: Child; Child, Preschool; Cosyntropin; Cytokines; Drug Therapy, Combination; Female; Follow-Up Studies; Hormones; Humans; Immunization, Passive; Immunoglobulins, Intravenous; Immunologic Factors; Infant; International Cooperation; Male; Opsoclonus-Myoclonus Syndrome; Rituximab; Severity of Illness Index; Treatment Outcome	2018

Article

Year

Rituximab, IVIg, and Tetracosactide (ACTH1-24) Combination Immunotherapy ("RITE-CI") for Pediatric Opsoclonus-Myoclonus Syndrome: Immunomarkers and Clinical Observations.

Neuropediatrics, 2018, Volume: 49, Issue:2

Topics: Child; Child, Preschool; Cosyntropin; Cytokines; Drug Therapy, Combination; Female; Follow-Up Studies; Hormones; Humans; Immunization, Passive; Immunoglobulins, Intravenous; Immunologic Factors; Infant; International Cooperation; Male; Opsoclonus-Myoclonus Syndrome; Rituximab; Severity of Illness Index; Treatment Outcome

2018